Sagimet Biosciences Presents Preclinical Results Supporting the Therapeutic Potential of its …

SAN MATEO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company …